No photo of Carla Maria Lourenco Alves

Carla Maria Lourenco Alves

If you made any changes in Pure these will be visible here soon.

Research Output

2018
Open Access
File
163 Downloads (Pure)
2016

CDK6 as a predictive marker of response to fulvestrant treatment and a potential indicator of benefit from CDK4/6 inhibitor therapy in estrogen receptor-positive metastatic breast cancer

Alves, C. M. L., Elias, D., Lyng, M. B., Bak, M., Lykkesfeldt, A. E. & Ditzel, H., 9. Jul 2016.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

High CDK6 protects cells from fulvestrant-mediated apoptosis and is a predictor of resistance to fulvestrant in estrogen receptor-positive metastatic breast cancer

Alves, C. M. L., Elias, D., Lyng, M. B., Bak, M., Kirkegaard, T., Lykkesfeldt, A. E. & Ditzel, H. J., Nov 2016, In : Clinical Cancer Research. 22, 22, p. 5514-5526

Research output: Contribution to journalJournal articleResearchpeer-review

Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer

Joshi, T., Elias, D., Stenvang, J., Alves, C. M. L., Teng, F., Lyng, M. B., Lykkesfeldt, A. E., Brünner, N., Wang, J., Gupta, R., Workman, C. & Ditzel, H., 2016, In : Oncotarget. 7, 35, p. 57239-57253

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
179 Downloads (Pure)
2015

High expression of CDK6 confers resistance to fulvestrant in breast cancer cells and is a potential predictor of fulvestrant treatment failure in estrogen receptor-positive breast cancer

Alves, C. M. L., Elias, D., Lyng, M. B., Bak, M., Lykkesfeldt, A. E. & Ditzel, H., 7. Feb 2015.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

File
96 Downloads (Pure)

High expression of CDK6 protects breast cancer cells from fulvestrant-mediated apoptosis and is a predictor of resistance to fulvestrant treatment in estrogen receptor-positive metastatic breast cancer

Alves, C. M. L., Elias, D., Lyng, M. B., Bak, M., Lykkesfeldt, A. & Ditzel, H., 2015.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

High expression of SNAI2 is associated with the emergence of a highly motile fulvestrantresistant phenotype and is an indicator of poor response to endocrine treatment in estrogen receptorpositive metastatic breast cancer

Alves, C. M. L., Elias, D., Lyng, M. B., Bak, M., Lykkesfeldt, A. & Ditzel, H., 2015.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review